Anne Wojcicki, 23andMe CEO
January 18, 2024 01:04 PM ESTUpdated January 19, 09:29 AM
People
Pharma

'Peo­ple want vanil­la ice cream': CEO Anne Wo­j­ci­c­ki grap­ples with 23and­Me's dual iden­ti­ty

Andrew Dunn

Senior Biopharma Correspondent

SAN FRAN­CIS­CO — 23andMe CEO Anne Wo­j­ci­c­ki said she’s “open to all ideas” in ad­dress­ing in­vestor con­fu­sion and turn­ing around a dis­ap­point­ing start to the ge­nom­ic …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Cal­tech spin­out de­buts with AI-dri­ven 'mir­ror pep­tide' plat­form

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times